Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiac arrhythmia
Research
Novartis' Jakavi has repurposing potential in heart arrhythmia
The JAK1/2 inhibitor blocks the heart version of an enzyme called CaMKII, new mouse and cell studies showed, and stops arrhythmias in their tracks.
Helen Floersh
Jun 27, 2023 11:30am
Scientists light up the heart to treat afib
Jun 26, 2023 11:30am
Volta Medical recharges with €36M for arrhythmia AI
Jan 5, 2023 10:55am
After 2020 flop, Milestone's arrhythmia spray hits in phase 3
Oct 17, 2022 6:00am
How an OTC cough med could help design arrhythmia drugs
Feb 18, 2022 11:54am
